Get the Stockscreener App
7.91
0.70%
0.06
Avita Medical Inc stock is traded at $7.91, with a volume of 161.16K.
It is up +0.70% in the last 24 hours and up +55.00% over the past month.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$7.85
Open:
$7.91
24h Volume:
161.16K
Relative Volume:
0.38
Market Cap:
$244.94M
Revenue:
$72.35M
Net Income/Loss:
$-45.34M
P/E Ratio:
-5.0366
EPS:
-1.5705
Net Cash Flow:
$-32.43M
1W Performance:
+4.01%
1M Performance:
+55.00%
6M Performance:
+83.41%
1Y Performance:
+40.41%
1-Day Range:
$7.74
$8.15
1-Week Range:
$7.52
$8.55
52-Week Range:
$3.22
$8.55
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
7.92 | 242.78M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
109.68 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.39 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.62 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.45 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.73 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-26 | Initiated | Northland Capital | Outperform |
| Nov-20-25 | Upgrade | BTIG Research | Sell → Neutral |
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical, Inc. (RCEL) Shareholder/Analyst CallSlideshow (NASDAQ:RCEL) 2026-08-16 - Seeking Alpha
Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18% - MarketBeat
Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds - MarketBeat
AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript - AOL.com
Avita Medical Inc. (ASX:AVH) Share Price Remains Unchanged as Stock Trades Within Daily Range - Kalkine
AVITA Medical at canaccord growth conference: growth resumes By Investing.com - Investing.com Canada
AVITA Medical Inc (ASX:AVH) Shares Reach 52-Week High at AUD 2.30 - Kalkine
Avita Medical Issues 7,260 Restricted US Stock Units to Key Management Personnel - Kalkine
Form 8K Avita Medical Ltd For: 11 August By Investing.com - Investing.com Nigeria
Avita Medical amends agreement with Stedical Scientific to expand distribution rights - Investing.com
Avita Medical Inc. (ASX:AVH) Share Market Overview and Biotechnology Sector Profile - Kalkine
Avita Medical Target Price Raised 52% to A$1.90/Share by Canaccord Genuity>AVH.AU - Moomoo
Avita Medical Company Profile & Introduction - Moomoo
AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVITA Medical to Showcase at Canaccord Genuity 46th Annual Growth Conference in Boston - Kalkine Media
Avita Medical Upgraded to Speculative Buy From Speculative Hold by Bell Potter - Moomoo
AVITA Medical Announces Investor Webinar on August 12, 2026, Featuring Q2 Earnings Overview - Kalkine Media
Avita Medical(RCEL) Stock Options Chain | Quotes & News - Moomoo
Can AVITA Medical (ASX:AVH) Turn RECELL Momentum Into More? - Kalkine Media
AVITA Medical to host investor webinar on Q2 20... - Pluang
Avita Medical hosts investor webinar briefing led by CEO Cary Vance, CFO David O’Toole - Bitget
Guess which ASX stock could rise 35% - The Motley Fool Australia
Investors Can Question AVITA Medical Executives on Aug. 12 - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Is Expected To Breakeven In The Near Future - Moomoo
Avita Medical (NASDAQ:RCEL) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
This SpaceX Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Sahm
BTIG Upgrades Avita Medical(RCEL.US) to Buy Rating, Announces Target Price $7 - Moomoo
AVITA Medical Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $12 - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference - Investing News Network
AVITA Medical to present at Canaccord Genuity G... - pluang.com
Avita Medical Inc (ASX: AVH) Share Price Update: Stock Rises as Health Care Index Closes Lower - Kalkine
CEO Cary Vance to Speak at AVITA Medical Conference Aug. 12 - Stock Titan
AVITA Medical, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
BTIG Upgrades AVITA Medical to Buy From Neutral, $7 Price Target - marketscreener.com
RCEL Upgraded by BTIG -- Price Target Announced at $7.00 - GuruFocus
Why (RCEL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Avita Medical Shares Surge After Record Second-Quarter Performance - Yahoo Finance
Avita Medical stock rating upgraded to buy at BTIG on revenue beat - Investing.com Canada
Avita Medical Price Target Announced at $7.00/Share by BTIG - Moomoo
Avita Medical Q2 Earnings Call Highlights - TradingView
Why is Avita Medical stock surging 20% today? By Investing.com - Investing.com Canada
Why James Hardie, Avita Medical and ResMed shares are turning heads on Friday - The Motley Fool Australia
Is AVITA Medical Inc (RCEL) Undervalued After Q2 Earnings? EPS a - GuruFocus
AVITA Medical Shares Climb 16.41% as ASX:AVH Approaches a Key 2026 Earnings Checkpoint - Kalkine
AVITA Medical (ASX:AVH) share price soars 16% on strong 2026 second quarter - Rask Media
AVITA Medical, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:RCEL) 2026-08-06 - Seeking Alpha
ASX Healthcare Stocks Show Operational Progress as ResMed and AVITA Medical Deliver Encouraging Updates - Kalkine
AVITA Medical Reports Revenue Growth and Targets Cash Flow Breakeven in 2026 - Kalkine
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Woody Joseph Fralin | Director |
Jun 09 '26 |
Buy |
4.19 |
10,000 |
41,900 |
102,761 |
| Woody Joseph Fralin | Director |
Jun 03 '26 |
Buy |
4.09 |
10,000 |
40,949 |
92,761 |
| Woody Joseph Fralin | Director |
Jun 01 '26 |
Buy |
4.30 |
10,000 |
43,000 |
10,000 |
| Woody Joseph Fralin | Director |
Jun 02 '26 |
Buy |
4.19 |
10,000 |
41,936 |
20,000 |
| O'Toole David D | CFO |
May 20 '26 |
Buy |
4.26 |
2,000 |
8,520 |
145,927 |
| O'Toole David D | CFO |
May 19 '26 |
Buy |
4.24 |
2,000 |
8,480 |
143,927 |
| O'Toole David D | CFO |
Feb 19 '26 |
Buy |
4.15 |
3,000 |
12,450 |
140,127 |
| McNamara Robert | Director |
Aug 28 '25 |
Buy |
4.50 |
10,000 |
45,000 |
86,771 |
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):